EP3471562 - SYNTHETIC COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE THE PREVENTION AND TREATMENT OF DISORDERS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 22.03.2019 Database last updated on 06.12.2019 | |
Former | The international publication has been made Status updated on 28.12.2017 | Most recent event Tooltip | 16.08.2019 | Change: Validation states | published on 18.09.2019 [2019/38] | 16.08.2019 | Change - extension states | published on 18.09.2019 [2019/38] | Applicant(s) | For all designated states Glycom A/S Kogle Allé 4 2970 Hørsholm / DK | [2019/17] | Inventor(s) | 01 /
VIGSNÆS, Louise Kristine Ravneholmsvej 20 2400 Copenhagen NV / DK | 02 /
MCCONNELL, Bruce 2 Chemin du Crêt à l'Igle 1814 La Tour de Peilz / CH | 03 /
ELISON, Emma Ernst Ahlgrensgatan 4B 217 59 Malmö / SE | [2019/17] | Representative(s) | Inspicos P/S Kogle Allé 2 2970 Hørsholm / DK | [2019/17] | Application number, filing date | 17812794.0 | 15.06.2017 | [2019/17] | WO2017DK50198 | Priority number, date | US201615183391 | 15.06.2016 Original published format: US201615183391 | US201615183404 | 15.06.2016 Original published format: US201615183404 | US201615183431 | 15.06.2016 Original published format: US201615183431 | [2019/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017215721 | Date: | 21.12.2017 | Language: | EN | [2017/51] | Type: | A1 Application with search report | No.: | EP3471562 | Date: | 24.04.2019 | Language: | EN | The application has been published by WIPO in one of the EPO official languages on 21.12.2017 | [2019/17] | Search report(s) | International search report - published on: | XN | 21.12.2017 | Classification | International: | A23L33/125, A61K31/702 | [2019/17] | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/17] | Title | German: | SYNTHETISCHE ZUSAMMENSETZUNGEN MIT MUTTERMILCHOLIGOSACCHARIDEN ZUR VORBEUGUNG UND BEHANDLUNG VON ERKRANKUNGEN | [2019/17] | English: | SYNTHETIC COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE THE PREVENTION AND TREATMENT OF DISORDERS | [2019/17] | French: | COMPOSITIONS SYNTHÉTIQUES COMPRENANT DES OLIGOSACCHARIDES DU LAIT HUMAIN POUR L'UTILISATION DANS LA PRÉVENTION ET LE TRAITEMENT DE TROUBLES | [2019/17] | Entry into regional phase | 15.01.2019 | National basic fee paid | 15.01.2019 | Search fee paid | 15.01.2019 | Designation fee(s) paid | 15.01.2019 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 15.01.2019 | Examination requested [2019/17] | 12.08.2019 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.06.2019 | Renewal fee patent year 03 | Cited in | International search | [X]WO2013057061 (NESTEC SA (CH) [X] 1-24 * Cited in the application See entire document, in particular page 2, lines 1-4; page 3, line 20 page 4, line 7; page 4, lines 23-24; page 11, lines 16-19; page 14, lines 7-12; page 17, line 17 -page 18, line 2; and claims 1, 2, 5, 8 and 13-15 *; | [X]WO2014187464 (GLYCOM A/S (DK) [X] 1, 7-8, 15, 19-24 * Cited in the application See abstract; page 8, lines 12-15; page 10, lines 12-14; page 12, lines 13-15; page 16, line 16 - page 18, line 7; page 21, line 22 - page 22, line 15; tables 1-3; example; and claims 1, 10-12, and 24 *; | [X]WO2011119023 (N.V. NUTRICIA (NL) [X] 1-24 * See page 8, line 20 -page 10, line 8; page 11, lines 5-21; and claims 1, 7, 11, and 12-14 *; | [X]WO2009082214 (N.V. NUTRICIA (NL) [X] 1-24 * See page 2, lines 23-30; page 4, line 10 - page 5, line 4; page 15, lines 17 - 29; and claims 1, and 6-8 *; | [X]WO2007073192 (N.V. NUTRICIA (NL) [X] 1-24 * See page 1, lines 3-5; page 14, line 16 - page 15, line 8; page 15, lines 21-26; page 19, line 26 - page 20, line 7 and claims 1, 3, 7 and 11 *; | [X]WO2015164021 (MJN U.S. HOLDINGS LLC (US) [X] 23-24 * See claims 1-2 and 18-19 *; | [X]WO2009077352 (NESTEC S.A. (CH) [X] 23-24 * See abstract; page 4, line 9 - page 5, line 5; and claims 1 and 2 *; | [X]WO9843495 (ABBOTT LABORATORIES (US) [X] 23-24 * See abstract; page 1, lines 10-14; and claims *; | [PX]WO2016091265 (GLYCOM A/S (DK) [PX] 1-13, 15-17, 19-24 * See page 3, line 20 - page 5, line 19; page 5, lines 23-26; examples and claims *; | [E]WO2017129639 (NESTEC S.A. (CH) [E] 1-21, 23-24 * See page 21, lines 19-20; and claims 1, 6-8, and 13-17 *; | [E]WO2017129641 (NESTEC S.A. (CH) [E] 1, 6-8, 15-17, 19-24 * See page 1 , lines 15-32; page 22, lines 33-34; page 24, lines 9-17; page 27, lines 16-22; and claims 1-6, 9, 12 and 18 *; | [E]WO2017129648 (NESTEC S.A. (CH) [E] 1-2, 6-8, 15-17, 19-24 * See page 1, lines 15-21; page 23, lines 28-32; page 24, lines 15-19; and claims 1-2, 5-6, 8, and 14-15 *; | [E]WO2017129650 (NESTEC S.A. (CH) [E] 1-8, 15-21, 23-24 * See page 1, lines 19-31; page 3, line 30 - page 4, line 13; Page 21, lines 7-8; page 22, lines 4-15 and claims 1, 4-5, and 8 * |